Paul Abernathy - May 5, 2022 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
Director
Signature
/s/ J. Paul Abernathy
Stock symbol
NHC
Transactions as of
May 5, 2022
Transactions value $
$0
Form type
4
Date filed
5/6/2022, 01:59 PM
Previous filing
May 7, 2021
Next filing
May 13, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NHC Shares of Common Stock 27.2K May 5, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock [2022 Grant] Award $0 +7.5K $0.00 7.5K May 5, 2022 Common Stock 7.5K $69.19 Direct F1
holding NHC Option to Purchase Common Stock 5.79K May 5, 2022 Common Stock 5.79K $72.94 Direct
holding NHC Option to Purchase Common Stock 5.48K May 5, 2022 Common Stock 5.48K $61.90 Direct
holding NHC Option to Purchase Common Stock 5.9K May 5, 2022 Common Stock 5.9K $77.92 Direct
holding NHC Option to Purchase Common Stock 7.5K May 5, 2022 Common Stock 7.5K $64.64 Direct
holding NHC Option to Purchase Common Stock 7.5K May 5, 2022 Common Stock 7.5K $71.64 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).